ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,299Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 3001

$1.7M Total Retail Price of All Prescriptions

Rank: 25 out of 3001

941 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 941 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 941 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 19,498 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 814 663 1 2
SIMVASTATIN 784 678 2 1
METOPROLOL TARTRATE 774 615 3 8
HYDROCODONE-ACETAMINOPHEN 771 643 S3 4 7
LEVOTHYROXINE SODIUM 657 532 5 3
OMEPRAZOLE 574 473 6 4
FUROSEMIDE 552 472 7 6
AMLODIPINE BESYLATE 524 453 8 5
HYDROCHLOROTHIAZIDE 462 415 9 10
WARFARIN SODIUM 415 328 10 12
ATORVASTATIN CALCIUM 394 301 11 11
GABAPENTIN 392 304 12 14
TRAZODONE HCL 383 302 13 37
METFORMIN HCL 379 253 14 9
PRAVASTATIN SODIUM 361 318 15 13
CITALOPRAM HBR 322 232 16 16
POTASSIUM CHLORIDE 303 258 17 15
TRAMADOL HCL 302 242 18 17
MIRTAZAPINE 260 228 19 44
CLOPIDOGREL 249 215 20 28
DONEPEZIL HCL 237 227 21 27
FAMOTIDINE 228 173 22 68
KLOR-CON M20 223 173 23 52
OXYCODONE-ACETAMINOPHEN 213 134 S2 24 32
NAMENDA 203 203 25 40
SERTRALINE HCL 202 154 26 20
FENOFIBRATE 199 148 27 59
ATENOLOL 197 172 28 18
SPIRIVA 177 152 29 57
METOPROLOL SUCCINATE 176 142 30 19
PANTOPRAZOLE SODIUM 171 136 31 43
QUETIAPINE FUMARATE 170 135 32 66
LANTUS 168 116 33 47
GLIMEPIRIDE 161 153 34 31
PLAVIX 159 142 35 46
TAMSULOSIN HCL 159 122 35 29
LOSARTAN POTASSIUM 155 119 37 21
CARVEDILOL 154 130 38 25
ZETIA 141 125 39 69
DIVALPROEX SODIUM 139 74 40 70
VENLAFAXINE HCL ER 132 96 41 103
MELOXICAM 128 92 42 34
PREDNISONE 124 78 43 39
ESCITALOPRAM OXALATE 123 82 44 82
ALENDRONATE SODIUM 119 92 45 26
ALLOPURINOL 119 103 45 35
ZOLPIDEM TARTRATE 118 81 47 24
SINGULAIR 117 104 48 95
JANUVIA 117 99 48 54
CLONIDINE HCL 115 78 50 64
NOVOLOG 114 78 51 94
FENTANYL 112 74 S2 52 76
ENULOSE 111 83 53 192
CYCLOBENZAPRINE HCL 110 42 R 54 73
NEXIUM 105 81 55 23
CRESTOR 104 83 56 33
FLUTICASONE PROPIONATE 103 83 57 42
GENERLAC 102 75 58 173
ISOSORBIDE MONONITRATE ER 98 88 59 45
CARBIDOPA-LEVODOPA 98 86 59 97
CYMBALTA 98 40 59 53
NIASPAN 96 77 62 133
ROPINIROLE HCL 96 88 62 88
GLYBURIDE 93 68 R 64 62
BUSPIRONE HCL 92 47 65 91
NYSTATIN 90 65 66 149
OXYBUTYNIN CHLORIDE ER 88 49 67 79
OXYCODONE HCL-ACETAMINOPHEN 87 45 S2 68 81
LIPITOR 87 80 68 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 59 70 22
ENALAPRIL MALEATE 83 72 71 83
VERAPAMIL ER 81 54 72 102
DOXYCYCLINE HYCLATE 80 66 73 105
MONTELUKAST SODIUM 79 71 74 175
TRIAMTERENE-HCTZ 79 71 74 48
SYMBICORT 78 64 76 155
RISPERIDONE 78 66 76 63
FLUOXETINE HCL 77 61 78 61
PROAIR HFA 77 51 78 30
INSULIN SYRINGE 76 62 80 162
PROMETHAZINE HCL 75 35 R 81 93
CELEBREX 74 55 82 89
EVISTA 73 73 83 148
ENOXAPARIN SODIUM 73 36 83 318
OLANZAPINE 72 60 85 106
DIOVAN 72 68 85 50
SYNTHROID 70 70 87 71
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 54 87 77
LYRICA 69 39 89 87
NYSTOP 69 52 89 167
ACTOS 68 31 91 113
DIGOXIN 67 67 92 65
LEVOFLOXACIN 66 53 93 115
VANCOMYCIN HCL 66 30 93 398
FLUCONAZOLE 65 24 95 194
SPIRONOLACTONE 65 36 95 75
ADVAIR DISKUS 64 52 97 58
QUINAPRIL HCL 63 58 98 152
AMITRIPTYLINE HCL 63 30 R 98 85
LANSOPRAZOLE 62 55 100 140
IBUPROFEN 60 40 101 74
BENZTROPINE MESYLATE 60 51 R 101 127
LIDODERM 58 40 103 122
BACLOFEN 57 13 104 125
PAROXETINE HCL 57 42 104 60
NIFEDIPINE ER 56 43 106 154
DIOVAN HCT 56 45 106 109
AZITHROMYCIN 56 38 106 36
SODIUM CHLORIDE 56 18 106 199
LORAZEPAM 55 48 110 96
NAPROXEN 55 28 110 84
LEVETIRACETAM 54 35 112 112
OXYBUTYNIN CHLORIDE 54 34 112 120
LEVEMIR FLEXPEN 54 49 112 188
CIPROFLOXACIN HCL 54 45 112 56
PHENYTOIN SODIUM EXTENDED 53 31 116 126
KLOR-CON M10 52 29 117 138
ALBUTEROL SULFATE 51 33 118 99
RANITIDINE HCL 50 23 119 41
BENICAR 50 38 119 206
BETHANECHOL CHLORIDE 50 39 119 406
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.